GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Harvard Apparatus Regenerative Technology Inc (OTCPK:HRGN) » Definitions » Cyclically Adjusted Price-to-FCF

Harvard Apparatus Regenerative Technology (Harvard Apparatus Regenerative Technology) Cyclically Adjusted Price-to-FCF : (As of May. 18, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Harvard Apparatus Regenerative Technology Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Harvard Apparatus Regenerative Technology Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Apparatus Regenerative Technology Cyclically Adjusted Price-to-FCF Chart

Harvard Apparatus Regenerative Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Harvard Apparatus Regenerative Technology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF falls into.



Harvard Apparatus Regenerative Technology Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Harvard Apparatus Regenerative Technology's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Harvard Apparatus Regenerative Technology's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.069/131.7762*131.7762
=-0.069

Current CPI (Mar. 2024) = 131.7762.

Harvard Apparatus Regenerative Technology Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -6.785 100.560 -8.891
201409 -6.107 100.428 -8.013
201412 -6.242 99.070 -8.303
201503 -3.813 99.621 -5.044
201506 -3.957 100.684 -5.179
201509 -3.349 100.392 -4.396
201512 -2.418 99.792 -3.193
201603 -3.699 100.470 -4.852
201606 -2.050 101.688 -2.657
201609 -2.449 101.861 -3.168
201612 -3.572 101.863 -4.621
201703 -2.325 102.862 -2.979
201706 -1.702 103.349 -2.170
201709 -1.633 104.136 -2.066
201712 -0.816 104.011 -1.034
201803 -0.750 105.290 -0.939
201806 -0.337 106.317 -0.418
201809 -0.399 106.507 -0.494
201812 -0.385 105.998 -0.479
201903 -0.207 107.251 -0.254
201906 -0.317 108.070 -0.387
201909 -0.194 108.329 -0.236
201912 -0.187 108.420 -0.227
202003 -0.132 108.902 -0.160
202006 -0.124 108.767 -0.150
202009 -0.097 109.815 -0.116
202012 -0.109 109.897 -0.131
202103 -0.060 111.754 -0.071
202106 -0.063 114.631 -0.072
202109 -0.045 115.734 -0.051
202112 -0.088 117.630 -0.099
202203 -0.048 121.301 -0.052
202206 -0.101 125.017 -0.106
202209 -0.148 125.227 -0.156
202212 -0.147 125.222 -0.155
202303 -0.084 127.348 -0.087
202306 -0.112 128.729 -0.115
202309 -0.228 129.860 -0.231
202312 -0.087 129.419 -0.089
202403 -0.069 131.776 -0.069

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Harvard Apparatus Regenerative Technology  (OTCPK:HRGN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Harvard Apparatus Regenerative Technology Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Harvard Apparatus Regenerative Technology (Harvard Apparatus Regenerative Technology) Business Description

Traded in Other Exchanges
N/A
Address
84 October Hill Road, Suite 11, Holliston, MA, USA, 01746
Harvard Apparatus Regenerative Technology Inc is a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastrointestinal system and the airway resulting from cancer, trauma, or birth defects. The company's technology is based on its proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs.
Executives
Junli He director C/O NO.1, COUNTRY GARDEN ROAD, BEIJIAO TOWN, SHUNDE DISTRICT, FOSHAN F4 528300
James E. Shmerling director 975 JOHNSON FERRY ROAD, SUITE 450, ATLANTA GA 30342
Dst Capital Llc 10 percent owner C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Ronald J Packard director 2300 CORPORATE PARK DRIVE, HERNDON VA 20171
Jing Chen director C/O BIOSTAGE,INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 02110
Hong Yu officer: President C/O BIOSTAGE, INC. 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Damasio Joseph Luis Jr officer: Chief Financial Officer 14 NORFOLK AVENUE, SOUTH EASTON MA 02375
David Green director, officer: See Remarks C/O HARVARD BIOSCIENCE INC, 84 OCTOBER HILL ROAD, HOLLISTON MA 01746-1371
William Fodor officer: Chief Scientific Officer C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Peter A. Pellegrino officer: Interim VP of Finance C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Herman Sanchez director 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON MA 01746
James Mastridge officer: See Remarks C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746
Jeffrey E Young director 60 WESTVIEW STREET, LEXINGTON MA 02421
Wei Zhang director C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Ting Li director C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746